I-MED Radiology implements world-first artificial intelligence solution Annalise CXR
I-MED Radiology Network · Australia
I-MED Radiology Network implemented Annalise CXR, an AI chest x-ray decision-support solution developed by annalise.ai (an I-MED joint venture with Harrison.ai), across its 250 clinics nationwide, used by 350 radiologists daily. Annalise CXR detects 124 clinical findings and was, at launch, proven to improve the accuracy of radiologists in identifying over 100 clinical findings, supporting over 38,000 patient cases per month.
Overview
I-MED Radiology Network implemented Annalise CXR, an AI chest x-ray decision-support solution developed by annalise.ai (an I-MED joint venture with Harrison.ai), across its 250 clinics nationwide, used by 350 radiologists daily. Annalise CXR detects 124 clinical findings and was, at launch, proven to improve the accuracy of radiologists in identifying over 100 clinical findings, supporting over 38,000 patient cases per month.
This entry has 11 published fields tied to exact passages in an immutable source capture.
Inspect the highlighted sourceThe challenge
I-MED Radiology Network, Australia's leading diagnostic imaging provider, is excited to announce that it has implemented a cutting-edge artificial intelligence (AI) solution to help support its leading team of radiologists in the identification of chest disease and illness, which could improve health outcomes for patients.
The solution
I-MED implemented Annalise CXR, a chest x-ray decision-support AI solution developed by annalise.ai (an I-MED joint venture with Harrison.ai), across its 250 clinics nationwide, used daily by 350 radiologists. Annalise CXR detects 124 clinical findings and compares with just 75 findings found using the next most comprehensive CXR AI product; most CXR AI products are limited to fewer than 15 findings. It has been proven to improve the accuracy of radiologists in identifying over 100 clinical findings.
Reported business value
Annalise CXR supports over 38,000 patient cases each month, giving radiologists the confidence to report large volumes of data safely and consistently with minimal disruption to their normal workflow, and offering I-MED's patients and referrers an extra layer of clinical care and specialist support.
Sources
Open any source and check the claim yourself — that is the point of the register.
Other healthcare entries in the register.
Novo Nordisk builds AI drug discovery platform on Azure with Microsoft Research
Novo Nordisk partnered with Microsoft Research to build an AI platform on Azure AI and data stacks spanning regulatory affairs, early research, drug discovery and trial design, using Azure OpenAI Service, Azure Cosmos DB and Azure Kubernetes Service, with Power BI and Power Apps for collaboration. The platform includes a copilot for researchers, shared reasoning-chain templates, and governance/auditing of how data and models are used. The teams published early results on predictive AI models for cardiovascular disease risk detection, including an algorithm that Novo Nordisk says predicts patients' cardiovascular risk better than the best clinical standards, drawing on more than 100 years of insulin research data.
CDPHP modernizes infrastructure and improves medical data extraction with AWS AI/ML
CDPHP, a not-for-profit health plan serving 400,000 members in Upstate New York, used AWS services including Amazon Comprehend Medical, Amazon Textract, and Amazon SageMaker to automate its data processing pipeline for unstructured medical records and health data. The organization processed over seven million records during initial migration and now processes 3,000 electronic health records weekly. CDPHP achieved a 60% improvement in overall efficiency and reduced HEDIS report generation from 4-5 days (three data scientists) to two reports produced daily.
Mayo Clinic deploys NVIDIA DGX SuperPOD to accelerate pathology foundation models
Mayo Clinic deployed an NVIDIA DGX SuperPOD with NVIDIA DGX B200 systems to support foundation model development for pathomics, drug discovery and precision medicine. In partnership with Aignostics, Mayo Clinic built the Atlas pathology foundation model, trained on more than 1.2 million histopathology whole-slide images. The new infrastructure is reducing four weeks of pathology slide analysis work to one week.
Myriad Genetics speeds document processing with AWS GenAI Intelligent Document Processing Accelerator
Myriad Genetics partnered with the AWS Generative AI Innovation Center to replace an Amazon Textract/Comprehend pipeline with Amazon Bedrock foundation models (Nova Pro for classification, Nova Premier for extraction) using the open-source GenAI IDP Accelerator. Document classification accuracy rose from 94% to 98%, classification cost per page fell 77% (3.1 cents to 0.7 cents), and classification time fell 80% (8.5 minutes to 1.5 minutes per document). Automated key information extraction reached 90% accuracy matching the manual baseline, with a projected $132K in annual savings and 300 hours saved monthly across 9,000 prior authorizations in the Women's Health unit alone.
Was this helpful?
Your feedback helps us improve our use case database